Schorr; Steven M. – Trademark Portfolio
Entity Type: 98
Schorr; Steven M. has 5 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 2 are successfully registered — a 40% registration rate. The portfolio includes marks such as EXTENDED LONGEVITY and INTELLIGENT REMEDIES. Filings span 5 Nice Classification classes, with the highest activity in Class 5 (Pharmaceuticals) and Class 41 (Education & Entertainment). This trademark owner is based in Bronx, NY.
Bronx, NY
Showing of trademarks Trademarks
Trademark Classifications
Schorr; Steven M.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Education; providing of training; entertainment; sporting and cultural activities
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Schorr; Steven M. have?
Schorr; Steven M. has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 cancelled.
What trademark classes does Schorr; Steven M. file in?
Schorr; Steven M. files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 20 (Furniture), Class 36 (Insurance & Financial), Class 15 (Musical Instruments). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Schorr; Steven M.'s most well-known trademarks?
Schorr; Steven M.'s registered trademark portfolio includes well-known marks such as EXTENDED LONGEVITY and INTELLIGENT REMEDIES. These are among 2 currently registered trademarks in the portfolio.
What is Schorr; Steven M.'s trademark registration success rate?
Schorr; Steven M. has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.